Search

everythinglearnresearchcommunity

for

Search:↓

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Ocrelizumab may cause pancreatitis in some patients.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Cetuximab can cause skin cysts after acne-like eruptions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Imuvert can prevent some chemotherapy-induced hair loss.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Cetuximab can cause unusual hair growth and hair loss.

Biological therapy boosts the immune system to effectively fight melanoma.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

3D imaging effectively tracks skin changes in vitiligo treatment.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.